Skip to main content
SpringerLink
Log in

The Role of Healthy Lifestyle in the Primordial Prevention of Metabolic Syndrome Throughout Lifetime: What We Know and What We Need to Know

  • Chapter
  • First Online:
Healthy Lifestyle

Part of the book series: Integrated Science ((IS,volume 3))

Abstract

The incidence of metabolic syndrome including obesity, elevated blood pressure, dyslipidemia, and elevated blood glucose, has reached epidemic proportions in both pediatric and adult populations worldwide. The cost of treatment of metabolic-related diseases is a major concern to health care community. Suboptimal lifestyle behaviors, including poor nutrition, physical inactivity, and smoking habits as well as environmental exposures leading causes of preventable metabolic-related diseases. The process of metabolic syndrome begins in childhood and tracks for decades, leading to hypertension, cardiovascular events, diabetes mellitus, chronic kidney disease, stroke and sudden death during adulthood. Population-based and clinical studies have shown that healthy lifestyle from early childhood including healthy maternal diet, reducing salt intake, avoiding tobacco use, regular physical exercise, reducing the exposure to endocrine disruptor, as well as diet rich in vegetables and fruits and low in animal fats can prevent or retard the progression of metabolic syndrome later in life. Cost effective analyses suggest that public policy, community efforts and lifestyle modifications are likely to be cost-effective comparing with pharmacological treatment of risk factors. Early primordial prevention strategies of metabolic syndrome will provide great value in developing a healthier society and improved quality of life in older age. This article summarizes the rational and available data that support a healthy lifestyle approach to primordial prevention throughout life course and emphasis on the development of healthy lifestyle behaviors to reduce the risk of metabolic syndrome and its adverse heath consequences.

Graphical Abstract

Disease is an abnormal state of the body which primarily and independently produces a disturbance in the normal functions of the body. It may be an abnormality of temperature or from structure. Symptoms are a manifestation of some abnormal state in the body. It may be harmful as a colic pain or harmless as flushing of cheeks in peripneumonia. Avicenna

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Obesity: preventing and managing the global epidemic. Report of a World Health Organization consultation on obesity, Geneva, Switzerland, June 3–5, 1997. Geneva: WHO; 1998

    Google Scholar 

  2. Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PW et al (2006) Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 113:791–798

    Article  Google Scholar 

  3. Strasser T (1978) Reflections on cardiovascular diseases. Interdiscip Sci Rev 3:225–230

    Article  Google Scholar 

  4. Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K (2003) American Heart Association. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 107:1562–1566

    Google Scholar 

  5. Task Force on Research in Prevention of Cardiovascular Disease Task Force. National Heart, Lung, and Blood Institute task force report on research in prevention of cardiovascular disease. http://www.nhlbi.nih. gov/resources/docs/cvdrpt.htm. Accessed 15 Mar 2011

  6. Weintraub WS, Daniels SR, Burke L, Franklin BA, Goff DC, Hayman LL et al (2011) Value of primordial and primary prevention for cardiovascular disease. A policy statement from the American Heart Association. Circulation 124:967–990

    Google Scholar 

  7. The National Children’s Study. http://www.nationalchildrensstudy.gov/Pages/default.aspx. Accessed 18 Mar 2011

  8. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med 338:1650–1656

    Article  CAS  Google Scholar 

  9. McGill HC Jr, McMahan CA, Zieske AW, Malcolm GT, Tracy RE, Strong JP (2001) Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation 103:1546–1550

    Article  CAS  Google Scholar 

  10. Li S, Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM, Berenson GS (2003) Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA 290:2271–2276

    Article  CAS  Google Scholar 

  11. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14–22

    Article  Google Scholar 

  12. Kassi E, Pervaanidou P, Kaltsas G, Chrousos G (2001) Metabolic syndrome : definitions and controversies. BMC Med 9:48

    Article  Google Scholar 

  13. La Sala L, Pontriolo AE (2020) Prevention of diabetes and cardiovascular disease in obesity. Int J Mol Sci 21:E8178. https://doi.org/10.3390/ijms21218178

    Article  CAS  PubMed  Google Scholar 

  14. Abarca-Gomez L, Abdeeb Z, Hamid ZA, Abu-Rmeileh NM, Acosts-Cazares B, Acuin C et al (2017) Worldwide tends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 390:2627–2642

    Google Scholar 

  15. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KS et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645

    Article  CAS  Google Scholar 

  16. Ashwell M, Gunn P, Gibson S (2012) Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systemic review and meta-analysis. Obes Rev 13:275–286

    Article  CAS  Google Scholar 

  17. Bpvolini A, Garcia J, Andrade MA, Durate JA (2020) Metabolic syndrome pathophysiology and predisposing factors. Int J Sport Med. https://doi.org/10.1055/a-1263-0898

  18. Esteve M (2020) Mechanisms underlying biological effects of cruciferous glucosinolate-derived isothiocyanates/indoles: a focus on metabolic syndrome. Front Nutr 7:111. https://doi.org/10.3389/frnut.2020.00111

  19. Martins AR, Nachbar RT, Gorjao R, Vinolo MA, Festuccia WT, Lambertucci RH et al (2012) Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function. Lipids Health Dis 11:30

    Article  CAS  Google Scholar 

  20. Smith DO, LeRoith D (2004) Insuline resistance syndrome, prediabetes, and the prevention of type 2 diabetets mellitus. Clin Cornerstone 6:7–6

    Article  Google Scholar 

  21. Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, Bazzarre T (2002) Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young American Heart Association. Circulation 106:143–160

    Article  Google Scholar 

  22. National Institutes of Health. National Heart, Lung, and Blood Institute. NHLBI Pediatric Guidelines for Cardiovascular Health and Risk Reduction. http://www.nhlbi.nih.gov/guidelines/cvd_ped/. Accessed 24 June 2011

  23. Barlow SE; Expert Committee (2007) Expert Committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 120(suppl 4):S164–S192

    Article  Google Scholar 

  24. Urbina EM, Kimball TR, McCoy CE, Khoury PR, Daniels SR, Dolan LM (2009) Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation 119:2913–2919

    Article  CAS  Google Scholar 

  25. US Department of Health and Human Services. Healthy People 2020: the road ahead. http://www.healthypeople.gov/hp2020/. Accessed 29 Oct 2020

  26. Juonala M, Magnussen CG, Venn A, Dwyer T, Burns TL, Davis PH, Chen W, Srinivasan SR, Daniels SR, Kahonen M, Laitinen T, Taittonen L, Berenson GS, Viikari JS, Raitakari OT (2010) Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation2 122:2514–2520

    Google Scholar 

  27. Centers for Disease Control and Prevention (CDC) (2010) Prevalence of abnormal lipid levels among youths: United States, 1999–2006. MMWR Morb Mortal Wkly Rep 9:29–33

    Google Scholar 

  28. Din-Dzietham R, Liu Y, Bielo MV, Shamsa F (2007) High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation 116:1488–1496

    Article  Google Scholar 

  29. Ogden CL, Carroll MD, Flegal KM (2008) High body mass index for age among US children and adolescents, 2003–2006. JAMA 299:2401–2405

    Article  CAS  Google Scholar 

  30. Mozaffarian D, Afshin A, Benowitz NL, Bittner V, Daniels AR, Franch Ha et al (2012) Population approaches to improve diet, physical activity and smoking habits. Circulation 126:1514–1563

    Google Scholar 

  31. Claas SA, Arnett DK (2016) The role of healthy life style in the primordial prevention of cardiovascular disease. Curr Cardiol Rep 18:56. https://doi.org/10.1007/s11886-016-0728-7

  32. Barbosa CM, Figueiredo VP, Barbosa MA, Cardosa LM (2020) Maternal high fat triggers metabolic syndrome disorders that are transferred to first and second offspring generations. British J Nutr 123:59–71. https://doi.org/10.1017/s0007114519002708

  33. Kelishadi R, Farajian S (2014) The protective effects of breastfeeding on chronic non-communicable diseases in adulthood: a review of evidence. Adv Biomed Res 3. https://doi.org/10.4103/2277-9175.124629

  34. Lloyd-Jones DM, Hong Y, Labarthe D, Mozafarian D, Appel LJ, Horn LV et al (2010) Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation 121:586–613

    Article  Google Scholar 

  35. Dhurandhar NV, Thomas D (2015) The link between dietary sugar intake and cardiovascular disease mortality: an unresolved question. JAMA 313:959–960

    Article  CAS  Google Scholar 

  36. Jalal DI, Smits G, Johnson RJ, Chonchol M (2010) Increased fructose associates with elevated blood pressure. J Am Soc Nephrol 21:1543–1549

    Google Scholar 

  37. Bjartveit K, Tverdal A (2005) Health consequences of smoking 1–4 cigarettes per day. Tob Control 14:315–320

    Article  CAS  Google Scholar 

  38. Stanhope KL, Medici V, Bremer AA, Lee V, Lam HD, Nunez MV et al (2015) A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults. Am J Clin Nutr 101:1144–1154

    Article  CAS  Google Scholar 

  39. Obarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller ER 3rd, Lin PH, Karanja NM et al (2001) Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Clin Nutr 74:80–89

    Article  CAS  Google Scholar 

  40. Berglund L, Lefevre M, Ginsberg HN, Kris-Etherton PM, Elmer PJ, Stewart PW et al (2007) Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr 86:1611–1620

    Article  CAS  Google Scholar 

  41. Whelton SP, Chin A, Xin X, He J (2002) Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 136:493–503

    Article  Google Scholar 

  42. Kelishadi R, Mansourian M, Heidari-Beni M (2014) Association of fructose consumption and components of metabolic syndrome in human studies: a systematic review and meta-analysis. Nutrition 30:503–510

    Article  CAS  Google Scholar 

  43. Aaron KJ, Sanders PW (2013) Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. Mayo Clin Proc 88:987–995

    Article  CAS  Google Scholar 

  44. Sousa N, Mendes R, Abrantes C, Sampaio J, Oliveira J (2013) A randomized 9-month study of blood pressure and body fat responses to aerobic training versus combined aerobic and resistance training in older men. Exp Gerontol 48:727–733

    Article  Google Scholar 

  45. Mensink RP, Zock PL, Kester AD, Katan MB (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77:1146–1155

    Article  CAS  Google Scholar 

  46. Falkner B, Lurbe E (2020) Primordial prevention of high blood pressure in children: an opportunity not to be missed. Hypertension 75. https://doi.org/10.1016./hypertensionaha.119.14059

    Google Scholar 

  47. Pearson TA, Bazzarre TL, Daniels SR, Fair JM, Fortman SP, Franklin BA et al (2003) American heart association guide for improving cardiovascular health at the community level. Circulation 107:655–651

    Google Scholar 

  48. Rocchini AP (1993) Adolescent obesity and hypertension. Pediatr Clin North Am 60:81–92

    Article  Google Scholar 

  49. Sacks FM, Campos H (2010) Dietary therapy in hypertension. N Engl J Med 362:2102–2012

    Article  CAS  Google Scholar 

  50. Apple LJ. Moore TJ, Obarzanek E, Vollmer WM, Svertkey LP, Sacks FM et al (1997) A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative Research Group. N Engl J Med 336:1117–1124

    Google Scholar 

  51. Moore LL, Bradlee ML, Singer MR, Qureshi MM, Buendia JR, Daniels SR (2012) Dietary approaches to stop hypertension (DASH) eating pattern and risk of elevated blood pressure in adolescent girls. Br J Nutr 108:1678–1685

    Google Scholar 

  52. Doring N, Ghaderi A, Bohman B et al (2016) Motivational interviewing to prevent childhood obesity: a cluster RCT. Pediatrics 137:1–1

    Google Scholar 

  53. Marcus BH, Williams DM, Dubbert PM, Sallis JF, King A, Yancey AK et al (2006) Physical activity intervention studies: what we know and what we need to know. A scientific statement from the American Heat Association Council on Nutrition, Physical Activity, and Metabolism. Circulation 114:2739–2752

    Google Scholar 

  54. Lu X, Zarean M, Fraszczk E, Van der Meer TP, van Fassen, Bloks VW et al (2020) An epigenome-wide association study identifies multiple DNA methylation markers of exposure to endocrine disruptors. Environ Int 144:106016. https://doi.org/10.1016/j.3nvint.2020.106016

  55. Zarean M, Poursafa P (2019) The role of environmental disruptor chemicals in the development of non communicable disease. Adv Exp Med Biol 1121:21–31. https://doi.org/10.1007/978-3-030-10616-4_3

  56. Papalou O, Kandaraki E, Papadakis G, Diamanti-Kandarakis E (2019) Endocrine disrupting chemicals: an occult mediator of metabolic disease. Front Endocrinol (Lausanne) 10:112. https://doi.org/10.3389/fendo.3019.00112

  57. Shu L et al (2019) Prenatal bisphenol a exposure in mice induces multitissue multiomics disruptions linking to cardiometabolic disorders. Endocrinology 160(2):409–429. https://doi.org/10.1210/en.2018-00817

    Article  CAS  PubMed  Google Scholar 

  58. Poursafa P, Dadvand P, Mehdi Amin M, Hajizadeh Y, Ebrahimpour K, Mansourian M et al (2018) Association of polycyclic aromatic hydrocarbons with cardiometabolic risk factors and obesity in children. Environ Int 118:203–210. https://doi.org/10.1016/j.envint.2018.05.048

    Article  CAS  PubMed  Google Scholar 

  59. Troiano RP, Flegal KM, Kuczmarski RJ, Campell SM, Johnson CL (1995) Overweight prevalence and trends for children and adolescents: the National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med 149:1085–1091

    Article  CAS  Google Scholar 

  60. Steinberger J, Daniels SR (2003) Obesity, insulin resistance diabetes, and cardiovascular risk in children. An American Heart Association Scientific Statement from the atherosclerosis, hypertension, and obesity in the young children. Circulation 107:1448–1453

    Google Scholar 

  61. Commission on Social Determinants of Health: Final Report. Geneva, Switzerland: World Health Organization; September 2, 2009

    Google Scholar 

Download references

Compliance with Ethical Standards

Funding Source

None.

Disclosure of Interests

All authors declare they have no conflict of interest.

Author’s Contributions

All authors have contributed sufficiently to the scientific work and therefore share collective responsibility and accountability for the work submitted.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Rush University Medical Center, Chicago, IL, USA

    Farahnak Assadi

  2. Department of Pediatrics, Semnan University of Medical Sciences, Semnan, Iran

    Mojgan Mazaheri

  3. Pediatrics Department and USERN Office, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran

    Roya Kelishadi

Authors
  1. Farahnak Assadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mojgan Mazaheri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roya Kelishadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Farahnak Assadi or Roya Kelishadi .

Editor information

Editors and Affiliations

  1. Pediatrics Department and USERN Office, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran

    Roya Kelishadi

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Assadi, F., Mazaheri, M., Kelishadi, R. (2022). The Role of Healthy Lifestyle in the Primordial Prevention of Metabolic Syndrome Throughout Lifetime: What We Know and What We Need to Know. In: Kelishadi, R. (eds) Healthy Lifestyle. Integrated Science, vol 3. Springer, Cham. https://doi.org/10.1007/978-3-030-85357-0_2

Download citation

Publish with us

Policies and ethics

Search

Navigation